Next Article in Journal
Phenylketonuria Diagnosis by Massive Parallel Sequencing and Genotype-Phenotype Association in Brazilian Patients
Previous Article in Journal
Age and Serum AMH and FSH Levels as Predictors of the Number of Oocytes Retrieved from Chromosomal Translocation Carriers after Controlled Ovarian Hyperstimulation: Applicability and Limitations
 
 
Article
Peer-Review Record

Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy

by Aleksei Zarubin 1,*,†, Vadim Stepanov 1,†, Anton Markov 1, Nikita Kolesnikov 1, Andrey Marusin 1, Irina Khitrinskaya 1, Maria Swarovskaya 1, Sergey Litvinov 2, Natalia Ekomasova 2, Murat Dzhaubermezov 2, Nadezhda Maksimova 3, Aitalina Sukhomyasova 3, Olga Shtygasheva 4, Elza Khusnutdinova 2, Magomed Radzhabov 5 and Vladimir Kharkov 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Submission received: 16 November 2020 / Revised: 18 December 2020 / Accepted: 21 December 2020 / Published: 25 December 2020
(This article belongs to the Section Molecular Genetics and Genomics)

Round 1

Reviewer 1 Report

General Comments

The manuscript describes the potential of TMPRSS2 as a potential drug target for COVID-19 based on structural information, cell and tissue-specific expression and identification of gene variations of TMPRSS2 in 76 populations in North Eurasia. Generally, the manuscript is clearly designed and relatively well written. However, before being accepted for publication, the authors are requested to revise it taking into account the comments/suggestions presented below.

Why is the Results and Discussion section presented before Materials and Methods? This is not according to the instructions for the journal.

The quality of Figs 7-9 is poor. Although I understand that the expression levels are low, it is really hard to get any indication based on the figures.

 

Specific Comments

Abstract

P1, L2: Delete “novel”, it is already a year since the outbreak started in China

Introduction

P1, L1: “Novel” > “The”

P1, L4: Define “ACE”

P2, L1: Define “BSG”

P2, L2: “P” in TMPRSS2” already stands for protease

P2, L9: “microRNAs; miRNAs” > “microRNAs (miRNAs)”

P2, L12 & 13: Define “ETS”, “ERG” and “ETV1”

P2, L19: “coronavirus of the” > “coronavirus responsible for”

P2, L20: “In this work” > “Here”

Results and Discussion

P2, L4: “co-expression between” > “co-expression of”

Figures 1 and 2

P2: The text in both figures is too small

P3, L4: “targeting......to the plasma membrane” is not clear

2.2

P3, L2: “a high level” > “high level”

Fig. 3: What is the message in the figure? In the text it is mentioned that high level expression is seen only in testicles, but “unknown” shows the same level of cell clusters. This does not make sense.

Figs 4 & 5: The text in the figures is too small

Author Response

Thank you for your comments and suggestions.
We accepted all your suggestions. The revised text can be found in the attached file.

Author Response File: Author Response.pdf

Reviewer 2 Report

This piece is relavant and interesting for readers.

There are, however, some corrections to be made, listed below.


Abstract

Line 1   The human serine protease serine 2  (TMPRSS2) instead of

The human serine protease serine 2  TMPRSS2

Line 4    Angiotensin-converting enzyme 2 (ACE-2)   instead of

ACE-2

Line  4    Basigin ( BSG ) instead of  BSG

 

Keywords: Also put ACE-2 and BSG.

 

             

Introduction

Pag 2  Line 8 : Delete one of the two brackets : (SNVs),indels)

 

Results and Discussion

Pag 2   Line 27 and 28 :   , GeneMANIA and STRING (Figs.1,2),  instead of  

( GeneMANIA and STRING )  (Figs. 1,2)

Pag 3   Line 1   :    BSG, or extracellular matrix metalloproteinase inducer (EMMPRIN) instead of  Basigin, or extracellular matrix metalloproteinase inducer 

 

 

                           

References

 

For references, follow in  Genes

Instructions for Authors:

Quick Reference Formatting Guide, indicating the DOI in all articles, if any, as indicated in red below:

  1. Bowman, C.M.; Landee, F.A.; Reslock, M.A. Chemically Oriented Storage and Retrieval System. 1. Storage and Verification of Structural Information. J. Chem. Doc.19677, 43-47; DOI:10.1021/c160024a013

 

Reference 24.

Paniri, A.; Hosseini, M.M.; Akhavan-Niaki, H. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. Journal of Biomolecular Structure and Dynamics 2020, 1–18; DOI: 10.1080/07391102.2020.1767690.

Instead of

Paniri, A.; Hosseini, M.M.; Akhavan-Niaki, H. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. Journal of Biomolecular Structure and Dynamics 2020, pp. 1–18.

 

 

Reference 31 should be replaced with a more recent analogue

Author Response

Thank you for your comments and suggestions.
We accepted all your suggestions. The revised text can be found in the attached file.

Author Response File: Author Response.pdf

Back to TopTop